05B · Claim Check

AlpE · BioVersys ENABLE · NCT06748937

Erasca says 44% of 25 responded; it’s Phase 1 · No. 052 · · About 1 min read

Readout
AlpE · BioVersys ENABLE · NCT06748937 (opens another website in a new tab)
What the registry or primary source says
Phase 2. Primary: early bactericidal activity over 14 days. N=60 (planned). Still reads recruiting past its 03.2026 primary completion date.
What the headline says
All regimens bactericidal; no values given
Verdict
Open

Bookmarks need a Mind Club sign-in. How sign-in works

Read it in Claim Check